SCPX.US Scorpius Holdings Inc

Healthcare Biotechnology USA Stocks
0.0002 USD
Close of Nov 17, 2026
0.0001 0.0400
Market cap
USD 12.2K
P/E
-
P/B
0.11x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 4 quarters up to Dec 2025.

Is SCPX.US undervalued?

Graham number

The Graham number of Scorpius Holdings Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Scorpius Holdings Inc fundamental analysis

No fundamental analysis for Scorpius Holdings Inc yet.

Scorpius Holdings Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Scorpius Holdings Inc

Scorpius Holdings, Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company engages in clinical and commercial drug substance manufacturing; and release and stability testing activities. It is also involved in the provision of various process development services, including upstream and downstream development and optimization, and analytical method development solutions, as well as cell…

Full company profile